Which hedge funds own CGEM? CULLINAN THERAPEUTICS INC, Q2 2026 13F holders
37 tracked hedge funds disclosed a position in CGEM (CULLINAN THERAPEUTICS INC) in their Q2 2026 13F filings, worth $608.4m in total. The largest holder by portfolio weight is Lynx1 Capital Management LP at 18.9% of its book. 7 opened a new position this quarter: Boone Capital Management LLC, Perceptive Advisors LLC, EntryPoint Capital, LLC, Campbell & CO Investment Adviser LLC. 9 exited: Superstring Capital Management LP, Cinctive Capital Management LP, Orbimed Advisors LLC.
- 37
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 7
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 9
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $28.9m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $13.2m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $608m
- Combined value Sum of the holders' reported positions in the security.
- 3.0%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Superstring Capital Management LP | 0.6% | $845k |
| Cinctive Capital Management LP | 0.09% | $1.3m |
| Orbimed Advisors LLC | 0.08% | $3.5m |
| Deerfield Management Company, L.P. | 0.06% | $5.5m |
| ADAR1 Capital Management, LLC | 0.04% | $711k |
| Gsa Capital Partners LLP | 0.04% | $616k |
| Seven Fleet Capital Management LP | 0.01% | $26.2k |
| Voleon Capital Management LP | 0.01% | $342k |
| Brevan Howard Capital Management LP | 0.0% | $342k |
Ownership over time
Who discovered CGEM first? Beta
The run: Q3 2025 → Q2 2026, +207%
| Kynam Capital Management, LP | Q4 2024 | 1.0% | +1.6 pts |
| Great Point Partners LLC | Q4 2025 | – | +1.1 pts |
| Affinity Asset Advisors, LLC | Q4 2025 | 0.1% | +0.8 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.